Abstract
It is a time of transition in the area of biomarkers. Confusion is rampant, progress immense and the challenges invigorating. Better diagnosis is possible if we progress in a rational way and avoid the chaos so often characteristic of transitions by relying on the science of the discipline to keep us on track.
MeSH terms
-
Biomarkers*
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / diagnosis*
-
Chest Pain / diagnosis
-
Diagnosis, Differential
-
Humans
-
Myocardial Reperfusion
-
Predictive Value of Tests
-
Sensitivity and Specificity
-
Troponin I / blood
-
Troponin T / blood
Substances
-
Biomarkers
-
Troponin I
-
Troponin T